Abstract
Gabapentin, a novel anticonvulsant originally developed for the treatment of seizure disorders, appears to be effective in the treatment of numerous difficult-to-treat pain conditions. These include migraine, peripheral neuropathy and postherpetic neuralgia, delegates were told at the 17th Annual Scientific Meeting of the American Pain Society [ San Diego, US; November 1998 ].
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Henahan, S. Gabapentin. Inpharma Wkly. 1172, 13–14 (1999). https://doi.org/10.2165/00128413-199911720-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199911720-00029